Companies

Pharmeasy raises $50 million in Series C funding

Priyanka Pani Mumbai | Updated on September 26, 2018

Dr Dhaval Shah, co-founder, PharmEasy

Online healthcare and pharma aggregator Pharmeasy has raised $50 million in Series C funding from Eight Roads Ventures India, the proprietary investment arm of Fidelity International Ltd.

The other investors are F-Prime Capital, Nandan Nilakeni, Sanjeev Aggarwal-backed Fundamentum Partnership and San Francisco-based hedge fund Think Investments.

Existing investors BVP also participated in this round which was run by investment banking firm Avendus. With this round, the total fund raised by Pharmeasy stands at $75 million. Its earlier investors include BVP, Orios Venture Partners, Aarin Capital and MEMG.

Founded in 2015 by Dharmil Sheth and Dhaval Shah, Pharmeasy connects patients to local pharmacies and diagnostic centres through an integrated online platform, making healthcare accessible and affordable across India via quick and efficient doorstep delivery and savings on their healthcare needs.

Pharmeasy will use the funds to expand the consumer base, improve the technology and expand into more cities. “The way we have grown in the last three years, more than 200% YOY is testament to the fact that affordable and accessible healthcare is very much possible,” the company’s founder, Dhaval Shah, said.

Dharmil Sheth, co-founder of Pharmeasy, said, “It has always been our aim to make healthcare affordable and accessible to everyone. And the new funding will only push us closer to achieving this goal, helping us change the healthcare ecosystem in the country. We plan to use this funds to strengthen our tech capabilities in operations and also in ensuring that we are able to provide personalised healthcare solutions to the consumers.’’

Pharmeasy provides e-consultation and at-home diagnostic tests, medicine dosage reminders and an automated medicine refill subscription service. It also specialises in chronic care segment, forming a significant part of its scope of services.

The start-up is also working on industry wide issues which revolve around eliminating fake medicines from the system by scrupulously validating prescriptions and barcoding every drug in its inventory to establish their genuineness. Currently, the company is delivering affordable and authentic healthcare solutions to more than 22000 pin codes.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on September 26, 2018
This article is closed for comments.
Please Email the Editor